ZA9705889B - HIV envelope polypeptides and vaccine. - Google Patents

HIV envelope polypeptides and vaccine.

Info

Publication number
ZA9705889B
ZA9705889B ZA9705889A ZA9705889A ZA9705889B ZA 9705889 B ZA9705889 B ZA 9705889B ZA 9705889 A ZA9705889 A ZA 9705889A ZA 9705889 A ZA9705889 A ZA 9705889A ZA 9705889 B ZA9705889 B ZA 9705889B
Authority
ZA
South Africa
Prior art keywords
vaccine
hiv envelope
envelope polypeptides
polypeptides
hiv
Prior art date
Application number
ZA9705889A
Inventor
Phillip W Berman
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US67673796A priority Critical
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of ZA9705889B publication Critical patent/ZA9705889B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse Transcribing RNA Viruses
    • C12N2740/00011Reverse Transcribing RNA Viruses
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16111Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
ZA9705889A 1996-07-08 1997-07-02 HIV envelope polypeptides and vaccine. ZA9705889B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US67673796A true 1996-07-08 1996-07-08

Publications (1)

Publication Number Publication Date
ZA9705889B true ZA9705889B (en) 1998-02-23

Family

ID=24715764

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9705889A ZA9705889B (en) 1996-07-08 1997-07-02 HIV envelope polypeptides and vaccine.

Country Status (13)

Country Link
US (1) US6090392A (en)
EP (1) EP0942988A1 (en)
JP (1) JP2000515368A (en)
AP (1) AP1282A (en)
AU (1) AU727107B2 (en)
CA (1) CA2259965A1 (en)
ID (1) ID17767A (en)
IL (2) IL127701D0 (en)
NZ (1) NZ333500A (en)
OA (1) OA10954A (en)
TW (1) TWI221846B (en)
WO (1) WO1998001564A1 (en)
ZA (1) ZA9705889B (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2903999A (en) 1998-03-12 1999-09-27 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Methods and compositions of chemokine-tumor antigen fusion proteins as cancer vaccines
AU785143B2 (en) 2000-02-04 2006-10-05 Beth Israel Deaconess Medical Center Human immunodeficiency virus vaccine
WO2001083535A2 (en) * 2000-05-02 2001-11-08 Simon Fraser University Polypeptides for use as a vaccine and/or treatment for hiv infection
US20030228320A1 (en) * 2000-08-18 2003-12-11 Ashdown Martin Leonard Retroviral immunotherapy
WO2002022687A2 (en) 2000-09-15 2002-03-21 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Viral chemokine-tumur antigen fusion proteins
WO2002022686A2 (en) 2000-09-15 2002-03-21 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, National Institutes Of Health, Office Of Technology Transfer Defensin-antigen fusion proteins
US20060116325A1 (en) * 2001-02-15 2006-06-01 Oleg Chertov Methods and compositions for inhibiting hiv-coreceptor interactions
AUPS054702A0 (en) * 2002-02-14 2002-03-07 Immunaid Pty Ltd Cancer therapy
AUPS065002A0 (en) 2002-02-20 2002-03-14 Immunaid Pty Ltd Strategy for retroviral immunotherapy
JP2006509039A (en) * 2002-12-03 2006-03-16 アドバンスド バイオサイエンス ラボラトリーズ インコーポレーティッド Multivalent primary HIV-1 glycoprotein DNA vaccine and vaccination method
KR20060041179A (en) * 2003-06-12 2006-05-11 박스젠 인코포레이티드 Hiv-1 envelope glycoproteins having unusual disulfide structure
US8076060B2 (en) * 2003-08-04 2011-12-13 Emil William Chynn Vaccination and immunotherapy as new therapeutic modalities in the treatment of glaucoma
AT490470T (en) 2003-10-24 2010-12-15 Immunaid Pty Ltd Therapy process
PL1805510T3 (en) * 2004-09-08 2012-07-31 Immunaid Pty Ltd Therapeutic strategy for treating autoimmune and degenerative diseases
CN101374550B (en) * 2004-09-14 2013-05-15 阿戈斯治疗公司 Strain independent amplification of pathogens and vaccines thereto
US8202523B2 (en) * 2005-09-22 2012-06-19 ProSci, Inc. Glycosylated polypeptides produced in yeast mutants and methods of use thereof
US8221981B2 (en) * 2007-07-30 2012-07-17 Argos Therapeutics, Inc. Primers and probes for the amplification and detection of HIV Gag, Rev and Nef polynucleotides
CN102123724B (en) 2008-06-19 2018-05-01 变异生技公司 Treat the composition and method of influenza
AU2010251880B2 (en) 2009-05-27 2015-07-30 Biotempus Pty Ltd Methods of treating diseases
WO2011005772A1 (en) 2009-07-06 2011-01-13 Variation Biotechnologies, Inc. Methods for preparing vesicles and formulations produced therefrom
ES2573427T3 (en) 2009-07-06 2016-06-07 Variation Biotechnologies Inc. Procedures for preparing vesicles and formulations produced from them
AU2011230619C1 (en) 2010-03-25 2016-06-23 Oregon Health & Science University CMV glycoproteins and recombinant vectors
AU2011276223C1 (en) 2010-07-06 2016-05-12 Variation Biotechnologies, Inc. Compositions and methods for treating influenza
EP2691530B1 (en) 2011-06-10 2018-03-07 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
US20130189754A1 (en) 2011-09-12 2013-07-25 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
EP2679596B1 (en) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 env glycoprotein variant
CN104955847A (en) 2012-12-04 2015-09-30 马里兰州大学(巴尔的摩) HIV-1 Env-binding antibodies, fusion proteins, and methods of use
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3588134D1 (en) * 1984-12-24 1997-01-23 Genentech Inc Mergers of AIDS-related polypeptides
DE3855869D1 (en) * 1987-02-20 1997-05-22 Genentech Inc Methods and compositions for the use of HIV env polypeptides and antibodies
IL89118D0 (en) * 1988-02-03 1989-08-15 Microgenesys Inc Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1
EP0339504A3 (en) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
US5116740A (en) * 1988-08-16 1992-05-26 Akzo N.V. Method for producing native hiv gp160
WO1991004273A2 (en) * 1989-09-22 1991-04-04 Idec Pharmaceuticals Corp. Novel peptides associated with the cd4 binding region of gp120 and their methods of use
AU7676891A (en) * 1990-04-03 1991-10-30 Genentech Inc. Hiv envelope polypeptides
DK527760T3 (en) * 1990-04-03 1995-11-27 Genentech Inc Methods and compositions for vaccination against HIV
CA2164505A1 (en) * 1993-06-07 1994-12-22 Phillip W. Berman Hiv envelope polypeptides

Also Published As

Publication number Publication date
AU727107B2 (en) 2000-11-30
CA2259965A1 (en) 1998-01-15
OA10954A (en) 2001-10-25
TWI221846B (en) 2004-10-11
WO1998001564A1 (en) 1998-01-15
IL127701D0 (en) 1999-10-28
ID17767A (en) 1998-01-22
AP9901432A0 (en) 1999-03-31
JP2000515368A (en) 2000-11-21
NZ333500A (en) 2000-09-29
AU3567797A (en) 1998-02-02
IL127701A (en) 2006-08-01
US6090392A (en) 2000-07-18
AP1282A (en) 2004-06-09
EP0942988A1 (en) 1999-09-22

Similar Documents

Publication Publication Date Title
EP1312679B8 (en) Recombinant MVA virus, and the use thereof
AU629669B2 (en) Diarylacetylenes, the preparations and use thereof
DK0757720T3 (en) Trimizing polypeptides, preparation and use thereof
AU4653989A (en) Biologically competent, virus inactivated albumin
EP0630658A3 (en) Hyterosalpingography and selective salpingography.
EP0635993A3 (en) Ceramic heater.
DK0758394T3 (en) Bifunctional protein, preparation and use
HK1005225A1 (en) Interferon conjugates
EP0684086A3 (en) Mail sorting.
IL143474A (en) Hapten-carrier conjugates and vaccines containing the same
GB2319515B (en) Corkscrew
AT505485T (en) Appetithemic peptide, composition and use
PL194894B1 (en) Solid, retarded-effect preparation
ZA9708868B (en) Vaccine composition
ZA9702041B (en) Pesticide.
AU2751395A (en) Helicobacter proteins and vaccines
ZA9702638B (en) Encapsulation.
IL112348A (en) 3-amino-2-phenylpiperidine and (2s, 3s)-3-amino-2- phenylpiperidine
ZA9703630B (en) Pesticide.
AU708903C (en) Human chemokine polypeptides
EP0647140A4 (en) Papillomavirus vaccines.
AU1914595A (en) Isolated antigenic oncogene peptide fragments and uses
ZA9709585B (en) Pesticidal methods, compositions and devices.
DE69838986D1 (en) Polypeptides, their preparation and use
HU0500549D0 (en) Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof